 Magenta Therapeutics NASDAQ:MGTA, a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced it will host a conference call on Thursday, May 7, 2020 at 8:00am ET to discuss recent business updates. The call will also feature a discussion of current stem cell transplant practices by a transplant key opinion leader. 